TP53 and posterior cortical atrophy: Underlying this perception is the fact or finding that the prevalence of somatic TP53 mutations in advanced forms of PCa is approximately 4 times the quantity in primary cancer17,18, which suggests that the genes with TP53 mutation status-associated transcription could be enriched with prognostic and etiological factors for cancer relapse.